Soy protein supplementation increases serum insulin-like growth factor-I in young and old men but does not affect markers of bone metabolism

Recent studies suggest that soy protein (SP) protects bone in women; however, its effects on bone metabolism in men have not been investigated. Healthy men (59.2 +/- 17.6 y) were assigned to consume 40 g of either SP or milk-based protein (MP) daily for 3 mo in a double-blind, randomized, controlled, parallel design. Serum insulin-like growth factor-1 (IGF-1), which is associated with higher rates of bone formation, was greater (P < 0.01) in men supplemented with SP than in those consuming MP. Serum alkaline phosphatalse and bone-specific alkaline phosphatase activities, markers of bone formation, and urinary deoxypyridinoline excretion, a specific marker of bone resorption, were not different between the SP and MP groups. Furthermore, because substantial reductions in bone density occur in men at similar to65 y of age, data were analyzed separately for men greater than or equal to 65 y and those < 65 y of age. The response to protein supplementation was consistent in the two age groups. The effects of SP on serum IGF-1 levels suggest that SP may positively influence bone in men. Longer-duration studies examining the effects, of SP or its isoflavones on bone turnover and bone mineral density and content in men are warranted.